Lipoprotein(a): Insights for the Practicing Clinician.
cardiovascular disease
lipoprotein(a)
thrombogenicity
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
25 Jun 2022
25 Jun 2022
Historique:
received:
25
05
2022
revised:
23
06
2022
accepted:
24
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
10
7
2022
Statut:
epublish
Résumé
Following the discovery of the Lipoprotein(a) (Lp(a)) molecule by Kare Berg in 1963, many physiological and pathological properties of this particle remain to be fully understood. Multiple population-based studies have demonstrated a correlation between elevated Lp(a) levels and the incidence of cardiovascular disease. Data extrapolated from the Copenhagen City Heart and ASTRONOMER studies also demonstrated the link between Lp(a) levels and the incidence and rate of progression of calcific aortic stenosis. Interest in Lp(a) has increased in recent years, partly due to new emerging therapies that can specifically reduce serum Lp(a) concentrations. Given the strong correlation between Lp(a) and CV disease from epidemiological studies, several international guidelines have also been updated to advocate Lp(a) testing in specific population groups. This review aims to highlight the importance of the role of Lp(a) in cardiovascular disease and discusses the potential of novel therapies in patients with elevated Lp(a) levels.
Identifiants
pubmed: 35806958
pii: jcm11133673
doi: 10.3390/jcm11133673
pmc: PMC9267912
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
N Engl J Med. 2020 Apr 16;382(16):1507-1519
pubmed: 32187462
Clin Chem. 2021 Jan 8;67(1):154-166
pubmed: 33236085
JAMA. 2009 Jul 22;302(4):412-23
pubmed: 19622820
Circulation. 2019 Mar 19;139(12):1472-1482
pubmed: 30667276
JAMA Cardiol. 2020 Oct 06;:
pubmed: 33021622
JAMA. 2021 Jul 27;326(4):352-353
pubmed: 34236417
Eur Heart J Suppl. 2020 Nov 18;22(Suppl L):L53-L56
pubmed: 33239979
J Lipid Res. 2016 May;57(5):745-57
pubmed: 26647358
N Engl J Med. 2020 Jan 16;382(3):244-255
pubmed: 31893580
Prague Med Rep. 2019;120(2-3):39-51
pubmed: 31586503
Glob Cardiol Sci Pract. 2015 Oct 09;2015(3):33
pubmed: 26779513
Cardiovasc Res. 2021 Jul 26;:
pubmed: 34314498
J Am Coll Cardiol. 2014 Feb 11;63(5):470-7
pubmed: 24161338
J Clin Lipidol. 2019 Jul - Aug;13(4):580-585
pubmed: 31130489
JAMA Cardiol. 2018 Dec 1;3(12):1212-1217
pubmed: 30476957
Atherosclerosis. 2009 Apr;203(2):371-6
pubmed: 18775538
J Am Coll Cardiol. 2015 Sep 15;66(11):1236-1246
pubmed: 26361154
Ann Clin Biochem. 2021 Jan;58(1):16-21
pubmed: 33040574
Cardiovasc Res. 2022 Mar 25;118(5):1218-1231
pubmed: 33769464
N Engl J Med. 2017 May 18;376(20):1933-1942
pubmed: 28514624
N Engl J Med. 2018 Oct 18;379(16):1519-1528
pubmed: 30221595
Vasc Health Risk Manag. 2021 Sep 07;17:527-542
pubmed: 34526771
JAMA Intern Med. 2021 Aug 1;181(8):1138-1139
pubmed: 34028487
Atherosclerosis. 2019 Dec;291:62-70
pubmed: 31704552
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):465-474
pubmed: 33115266
Data Brief. 2016 Apr 13;7:1409-12
pubmed: 27158659
Eur Heart J. 2020 Jun 21;41(24):2275-2284
pubmed: 31111151
Eur J Intern Med. 2021 Sep;91:33-39
pubmed: 33972150
J Thromb Haemost. 2006 May;4(5):973-5
pubmed: 16689745
J Lipid Res. 2017 Jan;58(1):1-14
pubmed: 27821413
Hellenic J Cardiol. 2020 Nov-Dec;61(6):398-403
pubmed: 33039574
Clin Cardiol. 2020 Dec 2;:
pubmed: 33289114
J Am Coll Cardiol. 1999 Mar 15;33(4):1005-12
pubmed: 10091828
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Can J Cardiol. 2021 Aug;37(8):1129-1150
pubmed: 33781847
Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):e48-e60
pubmed: 34647487
Circulation. 2014 Feb 11;129(6):635-42
pubmed: 24243886
J Am Coll Cardiol. 2019 Jun 25;73(24):3168-3209
pubmed: 30423391